Submitted by Anonymous (not verified) on 17 September 2024 - 15:00
Human medicines European public assessment report (EPAR): Roctavian, Valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 5, Status: Authorised
Source: